Evidence map›Paper›PMID 28512114›Full record

Observational studyJournal of the American Heart Association2017

Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.

Akiomi Yoshihisa, Mai Takiguchi, Yuki Kanno, Akihiko Sato, Tetsuro Yokokawa, Shunsuke Miura, Satoshi Abe, Tomofumi Misaka, Takamasa Sato, Satoshi Suzuki and 8 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Roles of Cardiovascular HFrontiers in pharmacology · 2021
    Review
  8. Observational
  9. Article
  10. Hypochlorhydria reduces mortality in heart failure caused by Kcne2 gene deletion.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Article
  12. Use of histamine HClinical epidemiology · 2018
    Article
  13. Cardiovascular Risk of Proton Pump Inhibitors.Methodist DeBakey cardiovascular journal
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Akiomi YoshihisaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan yoshihis@fmu.ac.jp.
Mai TakiguchiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yuki KannoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Akihiko SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tetsuro YokokawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Shunsuke MiuraDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi AbeDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tomofumi MisakaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takamasa SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi SuzukiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Masayoshi OikawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Atsushi KobayashiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takayoshi YamakiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Hiroyuki KuniiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Kazuhiko NakazatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Hitoshi SuzukiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Shu-Ichi SaitohDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Fukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been recently reported that histamine H METHODS AND

resultsIn total, 1191 consecutive heart failure patients were divided into 3 groups: a non-acid suppressive therapy group (n=363), an H2RA group (n=164), and a PPI group (n=664). In the follow-up period (mean 995 days), 169 cardiac deaths occurred. In the Kaplan-Meier analysis, cardiac mortality was significantly lower in the PPI group than in the H2RA and non-acid suppressive therapy groups (11.0% versus 21.3% and 16.8%, respectively; log-rank

conclusionsPPIs may be associated with better outcome in patients with heart failure.

Indexed as

AgedAged, 80 and overCardiovascular AgentsFemaleGastrointestinal DiseasesHeart FailureHistamine H2 AntagonistsHumansKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedMultivariate AnalysisPolypharmacyPrognosisPropensity ScoreCardiovascular AgentsHistamine H2 AntagonistsProton Pump Inhibitorsacid suppressive therapyheart failurehistamine H2 receptor antagonistsprognosisproton pump inhibitors

Identifiers

PMID28512114
PMCPMC5524076
OpenAlexW2616715279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.